New INSULIN Act seeks to cap monthly costs at $35 for millions

A new bipartisan bill, the INSULIN Act, aims to lower the cost of insulin for millions of Americans. The proposal would cap monthly expenses at $35 for those with private insurance. But with rising prices and uneven state protections, many still struggle to afford the life-saving medication. The bill was introduced by Senators Jeanne Shaheen, Raphael Warnock, Susan Collins, and John Kennedy. If passed, it would also launch a pilot program offering affordable insulin to uninsured people in 10 states. Yet the legislation faces challenges, including budget concerns and competing priorities in Congress.

Insulin costs vary dramatically across the U.S. Some patients pay hundreds of dollars each month, while others benefit from state-level co-pay caps. Over half of states have set their own limits, ranging from $25 to $100 per month. However, these protections don't cover everyone. Major insulin manufacturers have recently reduced prices, but gaps remain. In Mississippi, Marlee Brandon paid $194 last week for a one-month supply of vials and a three-month backup of pens for her toddler. She fears future price hikes could put the medication out of reach. Roughly 8.1 million Americans rely on insulin, including more than 2 million with Type 1 diabetes. Without consistent affordability measures, many risk financial strain or even rationing their doses.

The INSULIN Act could bring relief to millions if approved. For now, families like Brandon's continue to navigate unpredictable costs. The bill's fate will depend on whether lawmakers can overcome funding and scheduling obstacles in the coming months.